Effects of D-penicillamine on collagen biosynthesis by fibroblast cell cultures.

Author: ChamsonA, FreyJ

Paper Details 
Original Abstract of the Article :
The effects of D-penicillamine on collagen and total protein synthesis by fibroblast cell cultures were studied. High concentration of D-penicillamine (10 mmol/l) produced a toxic effect consisting of inhibition of growth and a non-specific increase in protein synthesis. A low concentration of D-pen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1440-1681.1985.tb00907.x

データ提供:米国国立医学図書館(NLM)

D-penicillamine's Impact on Collagen Biosynthesis: Exploring its Influence on Fibroblast Cell Cultures

This research explores the effects of D-penicillamine, a drug commonly used to treat various conditions, on collagen biosynthesis in fibroblast cell cultures. The study revealed that high concentrations of D-penicillamine (10 mmol/l) exhibited a toxic effect, inhibiting cell growth and causing a non-specific increase in protein synthesis. However, at a lower concentration (100 µmol/l), D-penicillamine demonstrated a specific reduction in the biosynthesis of both type I and type III collagen. This finding suggests a potential role for D-penicillamine in modulating collagen production, which could have implications for treating diseases involving collagen abnormalities.

D-penicillamine: A Double-Edged Sword in Collagen Production

This study demonstrates the complex interplay between D-penicillamine and collagen production. While high concentrations can be detrimental, lower doses specifically inhibit collagen biosynthesis. These findings emphasize the importance of carefully considering the dosage and potential impact of D-penicillamine when used for various medical conditions.

Implications for Collagen-Related Diseases and Drug Development

This research opens up potential avenues for understanding and potentially treating diseases involving collagen abnormalities. The study's findings suggest that D-penicillamine might be used to modulate collagen production, potentially aiding in the management of specific conditions. Further research is needed to explore the therapeutic potential of D-penicillamine in collagen-related diseases.

Dr.Camel's Conclusion

This study reminds us that even in the vast desert of medical research, there are hidden oases waiting to be discovered. D-penicillamine, with its potential to modulate collagen production, might be a key to unlocking new treatments for collagen-related diseases. It's a reminder that even seemingly simple molecules can hold the key to complex medical solutions.

Date :
  1. Date Completed 1986-07-24
  2. Date Revised 2019-08-24
Further Info :

Pubmed ID

3835038

DOI: Digital Object Identifier

10.1111/j.1440-1681.1985.tb00907.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.